Clinical-stage Medical Company Granted USPTO Allowance For Major Alzheimer's Treatment

Unveiling a New Era in Alzheimer's Treatment: BioXcel Therapeutics' Groundbreaking Patent Approval.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a significant stride towards addressing the unmet needs in Alzheimer's disease, BioXcel Therapeutics Inc., a clinical-stage biopharmaceutical company, has made a groundbreaking announcement. The United Stat…